Featured

Week in Review: FDA approves CBD drug, Arizona court bans marijuana extracts & federal cannabis reform

The FDA signs off on a cannabis-derived drug to treat epilepsy, an Arizona court says marijuana extracts are illegal in the state, and a bill that would deschedule MJ is introduced in Congress. Here’s a closer look at some notable developments in the cannabis industry over the past week. CBD’s ‘immutable support’ Marijuana advocates have […]

Read More

Local corruption becoming hurdle for marijuana license seekers in California

Allegations of corruption during competitive bidding for marijuana business licenses is far from a new phenomenon, especially in California, where tales of backdoor wheeling-and-dealing between companies and public officials have been circulating for years. But the state’s newly regulated market, launched in January, has brought the issue even more to the forefront, as illustrated by […]

Read More

July 1 could be ‘extinction event’ for some California cannabis businesses

Many California marijuana companies are worried if they will survive past the state’s July 1 deadline for complying with a comprehensive set of readopted and updated emergency regulations. The deadline to sell product that hasn’t passed mandated tests might even prove an “extinction event” for businesses struggling to comply, observed Pamela Epstein, founder of Los […]

Read More

$100M-$150M annual market projected as Oklahoma legalizes medical marijuana

Oklahoma voters on Tuesday approved an open-market medical marijuana program: no caps on the number of business licenses, and doctors can recommend MMJ for any patient ailment. Marijuana Business Daily projects that such an unrestricted MMJ market, if it sticks in its current form, could generate $100 million to $150 million in annual sales several […]

Read More

Chart: Medical cannabis as alternative to opioids could give Illinois’ MMJ program a massive boost

Pending legislation in Illinois that would allow medical marijuana as an alternative to opioid prescriptions could fundamentally alter the business landscape in the state. The move could potentially add tens of thousands of new patients to the MMJ program and eventually generate hundreds of millions in additional sales. The Illinois General Assembly on May 31 […]

Read More

Week in Review: Cannabis banking confusion, medical marijuana vs. opioids in NY & MMJ defeat in US Tax Court

Landmark news comes from Canada this week as it becomes the first G-20 nation to legalize recreational cannabis. Read more about that here.

In the United States, cannabis banking reform advocates get mixed signals, New York plans to allow the use of medical marijuana in lieu of opioids, and U.S. Tax Court denies a Colorado MMJ company’s business deductions.

Read More

MJ Freeway cannabis software system hits new glitch in Washington state; contract up for renewal

Marijuana business owners in Washington state continue to grapple with problems in the state-selected traceability program, with some industry officials concerned the situation could trigger errors tied to tax reporting and regulatory compliance. The state has used MJ Freeway’s Leaf Data Systems for its traceability software platform since December. The kinks plaguing the system come […]

Read More